share_log

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga Real-time News ·  Nov 23, 2022 05:36

Gainers

  • Conformis (NASDAQ:CFMS) shares increased by 14.0% to $2.2 during Tuesday's after-market session. The market value of their outstanding shares is at $16.5 million.
  • OpGen (NASDAQ:OPGN) stock increased by 13.1% to $0.22. The company's market cap stands at $11.7 million.
  • Predictive Oncology (NASDAQ:POAI) shares increased by 12.34% to $0.34. The company's market cap stands at $27.1 million.
  • Benitec Biopharma (NASDAQ:BNTC) shares moved upwards by 11.05% to $0.2. The market value of their outstanding shares is at $5.5 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 9.35% to $0.66. The company's market cap stands at $1.7 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 7.11% to $0.9. The market value of their outstanding shares is at $20.3 million.

Losers

  • Venus Concept (NASDAQ:VERO) stock declined by 8.6% to $0.2 during Tuesday's after-market session. The company's market cap stands at $13.5 million.
  • Cosmos Holdings (NASDAQ:COSM) stock decreased by 6.97% to $0.3. At the close, Cosmos Holdings's trading volume reached 13.1 million shares. This is 88.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $25.5 million.
  • Pulse Biosciences (NASDAQ:PLSE) stock decreased by 6.78% to $1.65. The market value of their outstanding shares is at $61.4 million.
  • SenesTech (NASDAQ:SNES) stock declined by 6.45% to $3.05. The company's market cap stands at $1.8 million.
  • Tenon Medical (NASDAQ:TNON) shares declined by 4.97% to $2.68. The company's market cap stands at $30.1 million.
  • PDS Biotechnology (NASDAQ:PDSB) shares decreased by 4.94% to $8.28. The company's market cap stands at $236.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment